Added to YB: 2024-07-30
Pitch date: 2024-06-30
ROG.SW [bullish]
Roche Holding AG
+31.44%
current return
Author Info
No bio for this author
Company Info
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
Market Cap
CHF 240.6B
Pitch Price
CHF 241.03
Price Target
369.00 (+16%)
Dividend
3.46%
EV/EBITDA
11.29
P/E
23.88
EV/Sales
4.21
Sector
Pharmaceuticals
Category
growth
Aristotle Capital International Equity New Position: Roche Holding AG
ROG.SW: Leading biotech/diagnostics co. w/ 58B CHF rev. Strong pharma (75%) & diagnostics (25%) portfolio. Personalized healthcare pioneer. Quality: innovative R&D, scale, expertise in targeted therapies. 30% upside at 14x P/E, 4% div yield. Catalysts: oncology gains, Hemlibra/Ocrevus growth, diagnostics value. Pipeline potential in neurological treatments.
Read full article (2 min)